Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-10-2022 | Splenectomy | Case report

Avatrombopag/eltrombopag/romiplostim

Various toxicities and lack of efficacy: 8 case reports

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Lee E-J, et al. Clinical outcomes in eight patients with immune thrombocytopenia each treated with the three approved thrombopoietin receptor agonists. American Journal of Hematology 96: E373-E376, No. 10, Oct 2021. Available from: URL: http://doi.org/10.1002/ajh.26277 Lee E-J, et al. Clinical outcomes in eight patients with immune thrombocytopenia each treated with the three approved thrombopoietin receptor agonists. American Journal of Hematology 96: E373-E376, No. 10, Oct 2021. Available from: URL: http://​doi.​org/​10.​1002/​ajh.​26277
Metadata
Title
Avatrombopag/eltrombopag/romiplostim
Various toxicities and lack of efficacy: 8 case reports
Publication date
01-10-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-26368-5

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Tigecycline

Case report

Adalimumab

Case report

Multiple drugs

Case report

Cemiplimab